`
`
`
`
`
`Filed: August 22, 2018
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`DR. REDDY’S LABORATORIES, INC.,
`Petitioner,
`v.
`CELGENE CORPORATION,
`Patent Owner.
`_____________
`
`Case IPR2018-01504
`U.S. Patent No. 9,056,120
`_____________
`
`PATENT OWNER’S MANDATORY NOTICES
`
`
`
`
`Case IPR2018-01504
`Patent 9,056,120
`Patent Owner’s Mandatory Notices
`
`
`Celgene Corporation, the Patent Owner, provides the following mandatory
`
`notices pursuant to 37 C.F.R. § 42.8.
`
`I.
`
`REAL PARTY-IN-INTEREST
`Pursuant to 37 C.F.R. § 42.8(b)(1), Patent Owner identifies Celgene
`
`Corporation (“Celgene”) as the real party-in-interest. Celgene is a corporation
`
`organized and existing under the laws of the State of Delaware, having a principal
`
`place of business at 86 Morris Avenue, Summit, New Jersey 07901, and is the
`
`owner of all right, title, and interest in U.S. Patent No. 9,056,120 (“the ’120
`
`patent”) by virtue of an assignment from the inventor, Jerome B. Zeldis. The
`
`Assignment was recorded on March 13, 2013 at Reel 029988, Frame 0502.
`
`II.
`
`RELATED MATTERS
`Pursuant to 37 C.F.R. § 42.8(b)(2), Patent Owner states the following:
`
`A.
`
`Proceedings Before the USPTO Involving the Patent-at-Issue
`The ’120 patent, which is the subject of this proceeding, is not at issue in any
`
`other inter partes review or inter partes reexamination proceedings.
`
`B.
`
`Proceedings Before the USPTO Involving Related Patents
`The ’120 patent is part of a family of related applications originating from
`
`U.S. Patent Application No. 10/411,649 and claiming priority to U.S. Provisional
`
`Application No. 60/418,468. Dr. Reddy’s Laboratories, Inc., the petitioner in the
`
`
`
`Case IPR2018-01504
`Patent 9,056,120
`Patent Owner’s Mandatory Notices
`
`present proceeding, also filed petitions with the PTAB for inter partes review of
`
`two other members of the patent family:
`
` IPR2018-01507, a petition for inter partes review of U.S. Patent No.
`
`8,404,717 (“the ’717 patent”)
`
` IPR2018-01509, a petition for inter partes review of U.S. Patent No.
`
`7,189,740 (“the ’740 patent”)
`
`C.
`
`Litigations Involving the Patent-at-Issue and Related Patents
`The ’740, ’120, and ’717 patents are the subject of the following pending
`
`litigations:
`
` Celgene Corp. v. Dr. Reddy’s Labs., Ltd. et al., No. 2:17-cv-05314-
`
`SDW-LDW (D.N.J. July 20, 2017)
`
` Celgene Corp. v. Lotus Pharm. Co., Ltd. et al., No. 2:17-cv-06842-
`
`SDW-LDW (D.N.J. Sept. 6, 2017)
`
`The ’740 patent was also the subject of the following litigation, which is no
`
`longer pending:
`
` Celgene Corp. v. Natco Pharma Ltd. et al., No. 2:12-cv-04571-SDW-
`
`MCA (D.N.J. July 20, 2012)
`
`The ’717 patent was also the subject of the following litigation, which is no
`
`longer pending:
`
`
`
`-2-
`
`
`
`Case IPR2018-01504
`Patent 9,056,120
`Patent Owner’s Mandatory Notices
`
`
` Celgene Corp. v. Natco Pharma Ltd. et al., No. 2:10-cv-05197-SDW-
`
`LDW (D.N.J. Oct. 8, 2010)
`
`III. LEAD AND BACKUP COUNSEL AND SERVICE INFORMATION
`In accordance with 37 C.F.R. §§ 42.8(b)(3), 42.8(b)(4) and 42.10(a), Patent
`
`Owner identifies the following lead and backup counsel and service information:
`
`Lead counsel:
`
`Christopher J. Harnett (Reg. No. 35,538)
`Jones Day
`250 Vesey Street
`New York, NY 10281
`Tel: (212) 326-3939
`Fax: (212) 755-7306
`Email: charnett@jonesday.com
`
`
`
`
`
`
`
`
`
`Backup counsel:
`
`J. Patrick Elsevier, Ph.D. (Reg. No.
`44,668)
`Celgene Corporation
`86 Morris Avenue
`Summit, NJ 07901
`Tel: (908) 673-9000
`Email: pelsevier@celgene.com
`F. Dominic Cerrito (Reg. No. 38,100)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`Email: nickcerrito@quinnemanuel.com
`Andrew S. Chalson (pro hac vice)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`Email: aminsogna @jonesday.com
`Cary Miller, Ph. D. (Reg. No. 54,708)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`Email: cmiller@jonesday.com
`
`Matthew J. Hertko (pro hac vice)
`Jones Day
`77 W. Wacker, Suite 3500
`
`
`
`-3-
`
`
`
`Chicago, IL 60601
`Tel: (312) 782-3939
`Fax: (312) 782-8585
`Email: mhertko@jonesday.com
`
`
`
`Case IPR2018-01504
`Patent 9,056,120
`Patent Owner’s Mandatory Notices
`
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`Email:
`andrewchalson@quinnemanuel.com
`Frank C. Calvosa (Reg. No. 69,064)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`Email:
`frankcalvosa@quinnemanuel.com
`
`
`
`Patent Owner consents to electronic service by email.
`
`Pursuant to 37 C.F.R. § 42.10(b), a Power of Attorney is being submitted to
`
`the Board herewith.
`
`
`
`Dated: August 22, 2018
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/s/ Christopher J. Harnett
`Christopher J. Harnett (Reg. No. 35,538)
`Jones Day
`250 Vesey Street
`New York, NY 10281
`Tel: (212) 326-3939
`Fax: (212) 755-7306
` Email: charnett@jonesday.com
`
`
`
`-4-
`
`
`
`Case IPR2018-01504
`Patent 9,056,120
`Patent Owner’s Mandatory Notices
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of the foregoing “Patent Owner’s
`
`Mandatory Notices” and the document captioned “Power of Attorney For
`
`Proceedings Before the Patent Trial and Appeal Board” by electronic means on
`
`August 22, 2018 at the following email addresses of record:
`
`
`
`
`
`Lead Counsel
`Brandon M. White
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, DC 20005
`Tel: (202) 654-6206
`Fax: (202) 654-9681
`Email: BMWhite@PerkinsCoie.com
`
`
`
`
`
`
`Backup Counsel
`Crystal R. Cantebury
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, DC 20005
`Tel: (202) 654-6383
`Fax: (202) 654-9962
`Email:
`CCanterbury@PerkinsCoie.com,
`lenalidomide@perkinscoie.com
`Emily J. Greb
`Perkins Coie LLP
`1 East Main Street, Suite 201
`Madison, WI 53703
`Tel: (608) 663-7494
`Fax: (608) 283-4494
`Email: EGreb@PerkinsCoie.com
`
`
`
`
`
`
`
`Case IPR2018-01504
`Patent 9,056,120
`Patent Owner’s Mandatory Notices
`
`
`Dated: August 22, 2018
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/s/ Christopher J. Harnett
`Christopher J. Harnett (Reg. No. 35,538)
`Jones Day
`250 Vesey Street
`New York, NY 10281
`Tel: (212) 326-3939
`Fax: (212) 755-7306
` Email: charnett@jonesday.com
`
`
`
`-6-
`
`